<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2017-05-10" version="194">
<accession>P50613</accession>
<accession>Q9BS60</accession>
<accession>Q9UE19</accession>
<name>CDK7_HUMAN</name>
<protein>
<recommendedName>
<fullName>Cyclin-dependent kinase 7</fullName>
<ecNumber>2.7.11.22</ecNumber>
<ecNumber>2.7.11.23</ecNumber>
</recommendedName>
<alternativeName>
<fullName>39 kDa protein kinase</fullName>
<shortName>p39 Mo15</shortName>
</alternativeName>
<alternativeName>
<fullName>CDK-activating kinase 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Cell division protein kinase 7</fullName>
</alternativeName>
<alternativeName>
<fullName>Serine/threonine-protein kinase 1</fullName>
</alternativeName>
<alternativeName>
<fullName>TFIIH basal transcription factor complex kinase subunit</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">CDK7</name>
<name type="synonym">CAK</name>
<name type="synonym">CAK1</name>
<name type="synonym">CDKN7</name>
<name type="synonym">MO15</name>
<name type="synonym">STK1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="J. Cell Biol." volume="127" first="467" last="478">
<title>Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase).</title>
<authorList>
<person name="Tassan J.-P."/>
<person name="Schultz S.J."/>
<person name="Bartek J."/>
<person name="Nigg E.A."/>
</authorList>
<dbReference type="PubMed" id="7929589"/>
<dbReference type="DOI" id="10.1083/jcb.127.2.467"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1994" name="Oncogene" volume="9" first="1977" last="1988">
<title>Two novel human serine/threonine kinases with homologies to the cell cycle regulating Xenopus MO15, and NIMA kinases: cloning and characterization of their expression pattern.</title>
<authorList>
<person name="Levedakou E.N."/>
<person name="He M."/>
<person name="Baptist E.W."/>
<person name="Craven R.J."/>
<person name="Cance W.G."/>
<person name="Welcsh P.L."/>
<person name="Simmons A."/>
<person name="Naylor S.L."/>
<person name="Leach R.J."/>
<person name="Lewis T.B."/>
<person name="Bowcock A."/>
<person name="Liu E.T."/>
</authorList>
<dbReference type="PubMed" id="8208544"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Mammary gland</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1994" name="Oncogene" volume="9" first="3127" last="3138">
<title>Cloning, expression and subcellular localization of the human homolog of p40MO15 catalytic subunit of cdk-activating kinase.</title>
<authorList>
<person name="Darbon J.-M."/>
<person name="Devault A."/>
<person name="Taviaux S."/>
<person name="Fesquet D."/>
<person name="Martinez A.-M."/>
<person name="Galas S."/>
<person name="Cavadore J.-C."/>
<person name="Doree M."/>
<person name="Blanchard J.-M."/>
</authorList>
<dbReference type="PubMed" id="7936635"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1994" name="Oncogene" volume="9" first="2089" last="2096">
<title>Molecular cloning of the human CAK1 gene encoding a cyclin-dependent kinase-activating kinase.</title>
<authorList>
<person name="Wu L."/>
<person name="Yee A."/>
<person name="Liu L."/>
<person name="Carbonaro-Hall D."/>
<person name="Venkatesan N."/>
<person name="Tolo T."/>
<person name="Hall F.L."/>
</authorList>
<dbReference type="PubMed" id="8208556"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Fibroblast</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1994" name="Oncol. Rep." volume="1" first="1269" last="1275">
<title>Human and Xenopus MO15 mRNA are highly conserved but show different patterns of expression in adult tissues.</title>
<authorList>
<person name="Kobelt D."/>
<person name="Karn T."/>
<person name="Hock B."/>
<person name="Holtrich U."/>
<person name="Braeuninger A."/>
<person name="Wolf G."/>
<person name="Strebhardt K."/>
<person name="Ruebsamen-Waigmann H."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Lung</tissue>
<tissue>Thymus</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2002-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS ALA-163 AND MET-285</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Cervix</tissue>
<tissue>Urinary bladder</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1994" name="Cell" volume="78" first="713" last="724">
<title>A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase.</title>
<authorList>
<person name="Fisher R.P."/>
<person name="Morgan D.O."/>
</authorList>
<dbReference type="PubMed" id="8069918"/>
<dbReference type="DOI" id="10.1016/0092-8674(94)90535-5"/>
</citation>
<scope>MUTAGENESIS OF THR-170</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1997" name="Mol. Cell. Biol." volume="17" first="7220" last="7229">
<title>p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner.</title>
<authorList>
<person name="Ko L.J."/>
<person name="Shieh S.-Y."/>
<person name="Chen X."/>
<person name="Jayaraman L."/>
<person name="Tamai K."/>
<person name="Taya Y."/>
<person name="Prives C."/>
<person name="Pan Z.-Q."/>
</authorList>
<dbReference type="PubMed" id="9372954"/>
<dbReference type="DOI" id="10.1128/MCB.17.12.7220"/>
</citation>
<scope>FUNCTION AS TP53 KINASE</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1998" name="Genes Dev." volume="12" first="3541" last="3550">
<title>The molecular mechanism of mitotic inhibition of TFIIH is mediated by phosphorylation of CDK7.</title>
<authorList>
<person name="Akoulitchev S."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="9832506"/>
<dbReference type="DOI" id="10.1101/gad.12.22.3541"/>
</citation>
<scope>PHOSPHORYLATION AT SER-164 AND THR-170</scope>
<scope>MUTAGENESIS OF SER-164 AND THR-170</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="34444" last="34453">
<title>Immunoaffinity purification and functional characterization of human transcription factor IIH and RNA polymerase II from clonal cell lines that conditionally express epitope-tagged subunits of the multiprotein complexes.</title>
<authorList>
<person name="Kershnar E."/>
<person name="Wu S.-Y."/>
<person name="Chiang C.-M."/>
</authorList>
<dbReference type="PubMed" id="9852112"/>
<dbReference type="DOI" id="10.1074/jbc.273.51.34444"/>
</citation>
<scope>IDENTIFICATION IN THE TFIIH BASAL TRANSCRIPTION FACTOR</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1998" name="Oncogene" volume="17" first="2733" last="2741">
<title>Regulation of CAK kinase activity by p53.</title>
<authorList>
<person name="Schneider E."/>
<person name="Montenarh M."/>
<person name="Wagner P."/>
</authorList>
<dbReference type="PubMed" id="9840937"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202504"/>
</citation>
<scope>FUNCTION AS CDK2 KINASE</scope>
<scope>IDENTIFICATION IN COMPLEX WITH TP53</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1999" name="Mol. Cell" volume="3" first="87" last="95">
<title>Reconstitution of the transcription factor TFIIH: assignment of functions for the three enzymatic subunits, XPB, XPD, and cdk7.</title>
<authorList>
<person name="Tirode F."/>
<person name="Busso D."/>
<person name="Coin F."/>
<person name="Egly J.-M."/>
</authorList>
<dbReference type="PubMed" id="10024882"/>
<dbReference type="DOI" id="10.1016/S1097-2765(00)80177-X"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2000" name="Mol. Cell" volume="5" first="331" last="341">
<title>The FBP interacting repressor targets TFIIH to inhibit activated transcription.</title>
<authorList>
<person name="Liu J."/>
<person name="He L."/>
<person name="Collins I."/>
<person name="Ge H."/>
<person name="Libutti D."/>
<person name="Li J."/>
<person name="Egly J.-M."/>
<person name="Levens D."/>
</authorList>
<dbReference type="PubMed" id="10882074"/>
<dbReference type="DOI" id="10.1016/S1097-2765(00)80428-1"/>
</citation>
<scope>INTERACTION WITH PUF60</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2001" name="Mol. Cell. Biol." volume="21" first="88" last="99">
<title>Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.</title>
<authorList>
<person name="Garrett S."/>
<person name="Barton W.A."/>
<person name="Knights R."/>
<person name="Jin P."/>
<person name="Morgan D.O."/>
<person name="Fisher R.P."/>
</authorList>
<dbReference type="PubMed" id="11113184"/>
<dbReference type="DOI" id="10.1128/MCB.21.1.88-99.2001"/>
</citation>
<scope>PHOSPHORYLATION AT SER-164 AND THR-170 BY CDK2</scope>
<scope>FUNCTION AS CDK2 KINASE</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2005" name="Tissue Cell" volume="37" first="53" last="58">
<title>Cyclin-dependent kinase activating kinase/Cdk7 co-localizes with PKC-iota in human glioma cells.</title>
<authorList>
<person name="Bicaku E."/>
<person name="Patel R."/>
<person name="Acevedo-Duncan M."/>
</authorList>
<dbReference type="PubMed" id="15695176"/>
<dbReference type="DOI" id="10.1016/j.tice.2004.10.004"/>
</citation>
<scope>INTERACTION WITH PRKCI</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Nat. Struct. Mol. Biol." volume="13" first="55" last="62">
<title>Dichotomous but stringent substrate selection by the dual-function Cdk7 complex revealed by chemical genetics.</title>
<authorList>
<person name="Larochelle S."/>
<person name="Batliner J."/>
<person name="Gamble M.J."/>
<person name="Barboza N.M."/>
<person name="Kraybill B.C."/>
<person name="Blethrow J.D."/>
<person name="Shokat K.M."/>
<person name="Fisher R.P."/>
</authorList>
<dbReference type="PubMed" id="16327805"/>
<dbReference type="DOI" id="10.1038/nsmb1028"/>
</citation>
<scope>FUNCTION AS SPT5/SUPT5H AND CDK KINASE</scope>
<scope>MUTAGENESIS OF PHE-91</scope>
<scope>IDENTIFICATION IN CAK COMPLEX</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="Mol. Cell" volume="25" first="839" last="850">
<title>Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells.</title>
<authorList>
<person name="Larochelle S."/>
<person name="Merrick K.A."/>
<person name="Terret M.-E."/>
<person name="Wohlbold L."/>
<person name="Barboza N.M."/>
<person name="Zhang C."/>
<person name="Shokat K.M."/>
<person name="Jallepalli P.V."/>
<person name="Fisher R.P."/>
</authorList>
<dbReference type="PubMed" id="17386261"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.02.003"/>
</citation>
<scope>FUNCTION IN CELL CYCLE REGULATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="Proteins" volume="67" first="1048" last="1059">
<title>Recognition of Cdk2 by Cdk7.</title>
<authorList>
<person name="Lolli G."/>
<person name="Johnson L.N."/>
</authorList>
<dbReference type="PubMed" id="17373709"/>
<dbReference type="DOI" id="10.1002/prot.21370"/>
</citation>
<scope>FUNCTION AS CDK2 KINASE</scope>
<scope>INTERACTION WITH CDK2</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7; SER-164 AND SER-321</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Mol. Endocrinol." volume="22" first="91" last="104">
<title>Phosphorylation of steroidogenic factor 1 is mediated by cyclin-dependent kinase 7.</title>
<authorList>
<person name="Lewis A.E."/>
<person name="Rusten M."/>
<person name="Hoivik E.A."/>
<person name="Vikse E.L."/>
<person name="Hansson M.L."/>
<person name="Wallberg A.E."/>
<person name="Bakke M."/>
</authorList>
<dbReference type="PubMed" id="17901130"/>
<dbReference type="DOI" id="10.1210/me.2006-0478"/>
</citation>
<scope>FUNCTION AS SF1/NR5A1 KINASE</scope>
<scope>INTERACTION WITH SF1/NR5A1</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-164 AND THR-170</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Mol. Cell" volume="34" first="387" last="393">
<title>TFIIH kinase places bivalent marks on the carboxy-terminal domain of RNA polymerase II.</title>
<authorList>
<person name="Akhtar M.S."/>
<person name="Heidemann M."/>
<person name="Tietjen J.R."/>
<person name="Zhang D.W."/>
<person name="Chapman R.D."/>
<person name="Eick D."/>
<person name="Ansari A.Z."/>
</authorList>
<dbReference type="PubMed" id="19450536"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.04.016"/>
</citation>
<scope>FUNCTION AS POLR2A CTD KINASE</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Mol. Cell. Biol." volume="29" first="613" last="625">
<title>SUMOylation inhibits SF-1 activity by reducing CDK7-mediated serine 203 phosphorylation.</title>
<authorList>
<person name="Yang W.-H."/>
<person name="Heaton J.H."/>
<person name="Brevig H."/>
<person name="Mukherjee S."/>
<person name="Iniguez-Lluhi J.A."/>
<person name="Hammer G.D."/>
</authorList>
<dbReference type="PubMed" id="19015234"/>
<dbReference type="DOI" id="10.1128/MCB.00295-08"/>
</citation>
<scope>FUNCTION AS SF1/NR5A1 KINASE</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="Mol. Cell. Biol." volume="29" first="5455" last="5464">
<title>TFIIH-associated Cdk7 kinase functions in phosphorylation of C-terminal domain Ser7 residues, promoter-proximal pausing, and termination by RNA polymerase II.</title>
<authorList>
<person name="Glover-Cutter K."/>
<person name="Larochelle S."/>
<person name="Erickson B."/>
<person name="Zhang C."/>
<person name="Shokat K."/>
<person name="Fisher R.P."/>
<person name="Bentley D.L."/>
</authorList>
<dbReference type="PubMed" id="19667075"/>
<dbReference type="DOI" id="10.1128/MCB.00637-09"/>
</citation>
<scope>FUNCTION AS POLR2A CTD KINASE</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2009" name="Nucleic Acids Res." volume="37" first="1260" last="1268">
<title>Binding to DNA of the RNA-polymerase II C-terminal domain allows discrimination between Cdk7 and Cdk9 phosphorylation.</title>
<authorList>
<person name="Lolli G."/>
</authorList>
<dbReference type="PubMed" id="19136461"/>
<dbReference type="DOI" id="10.1093/nar/gkn1061"/>
</citation>
<scope>FUNCTION AS POLR2A CTD KINASE</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2009" name="Peptides" volume="30" first="681" last="688">
<title>DNA-Bound peptides control the mRNA transcription through CDK7.</title>
<authorList>
<person name="Lv X."/>
<person name="Wang J."/>
<person name="Dong Z."/>
<person name="Lv F."/>
<person name="Qin Y."/>
</authorList>
<dbReference type="PubMed" id="19071173"/>
<dbReference type="DOI" id="10.1016/j.peptides.2008.11.008"/>
</citation>
<scope>FUNCTION IN DNA-BOUND PEPTIDES TRANSCRIPTION INHIBITION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-170</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="31">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="16978" last="16990">
<title>Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transition.</title>
<authorList>
<person name="Timofeev O."/>
<person name="Cizmecioglu O."/>
<person name="Settele F."/>
<person name="Kempf T."/>
<person name="Hoffmann I."/>
</authorList>
<dbReference type="PubMed" id="20360007"/>
<dbReference type="DOI" id="10.1074/jbc.M109.096552"/>
</citation>
<scope>FUNCTION AS CDK1 AND CDK2 KINASE</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2010" name="J. Cell. Biochem." volume="109" first="217" last="235">
<title>R-roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with cyclophosphamide: Inhibition of CDK7 sensitizes leukemic cells to caspase-dependent apoptosis.</title>
<authorList>
<person name="Rogalinska M."/>
<person name="Blonski J.Z."/>
<person name="Komina O."/>
<person name="Goralski P."/>
<person name="Zolnierczyk J.D."/>
<person name="Piekarski H."/>
<person name="Robak T."/>
<person name="Kilianska Z.M."/>
<person name="Wesierska-Gadek J."/>
</authorList>
<dbReference type="PubMed" id="19911397"/>
<dbReference type="DOI" id="10.1002/jcb.22400"/>
</citation>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2005" name="Cell Cycle" volume="4" first="572" last="577">
<title>CAK-Cyclin-dependent Activating Kinase: a key kinase in cell cycle control and a target for drugs?</title>
<authorList>
<person name="Lolli G."/>
<person name="Johnson L.N."/>
</authorList>
<dbReference type="PubMed" id="15876871"/>
</citation>
<scope>REVIEW ON CELL CYCLE REGULATION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2009" name="Nat. Rev. Cancer" volume="9" first="153" last="166">
<title>Cell cycle, CDKs and cancer: a changing paradigm.</title>
<authorList>
<person name="Malumbres M."/>
<person name="Barbacid M."/>
</authorList>
<dbReference type="PubMed" id="19238148"/>
<dbReference type="DOI" id="10.1038/nrc2602"/>
</citation>
<scope>REVIEW ON INHIBITORS</scope>
<scope>GENE FAMILY</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-170 AND SER-321</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="36">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2011" name="DNA Repair" volume="10" first="714" last="721">
<title>A history of TFIIH: Two decades of molecular biology on a pivotal transcription/repair factor.</title>
<authorList>
<person name="Egly J.M."/>
<person name="Coin F."/>
</authorList>
<dbReference type="PubMed" id="21592869"/>
<dbReference type="DOI" id="10.1016/j.dnarep.2011.04.021"/>
</citation>
<scope>REVIEW ON TRANSCRIPTION REGULATION</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-170</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-164 AND THR-170</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="41">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="42">
<citation type="journal article" date="2004" name="Structure" volume="12" first="2067" last="2079">
<title>The crystal structure of human CDK7 and its protein recognition properties.</title>
<authorList>
<person name="Lolli G."/>
<person name="Lowe E.D."/>
<person name="Brown N.R."/>
<person name="Johnson L.N."/>
</authorList>
<dbReference type="PubMed" id="15530371"/>
<dbReference type="DOI" id="10.1016/j.str.2004.08.013"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.02 ANGSTROMS) IN COMPLEX WITH ATP</scope>
<scope>ACTIVE SITE</scope>
<scope>PHOSPHORYLATION AT THR-170</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] MET-285</scope>
</reference>
<comment type="function">
<text evidence="11 13 16 18 19 20 21 22 23 24 25 27 29 31">Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of CDK1/cyclin-B during G2-M transition, and for activation of CDK2/cyclins during G1-S transition (but not complex formation). CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. Phosphorylates SPT5/SUPT5H, SF1/NR5A1, POLR2A, p53/TP53, CDK1, CDK2, CDK4, CDK6 and CDK11B/CDK11. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminal domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts. Phosphorylation of POLR2A in complex with DNA promotes transcription initiation by triggering dissociation from DNA. Its expression and activity are constant throughout the cell cycle. Upon DNA damage, triggers p53/TP53 activation by phosphorylation, but is inactivated in turn by p53/TP53; this feedback loop may lead to an arrest of the cell cycle and of the transcription, helping in cell recovery, or to apoptosis. Required for DNA-bound peptides-mediated transcription and cellular growth inhibition.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + [DNA-directed RNA polymerase] = ADP + [DNA-directed RNA polymerase] phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="26 31">Inactivated by phosphorylation. Repressed by roscovitine (seliciclib, CYC202), R547 (Ro-4584820) and SNS-032 (BMS-387032). The association of p53/TP53 to the CAK complex in response to DNA damage reduces kinase activity toward CDK2 and RNA polymerase II repetitive C-terminal domain (CTD), thus stopping cell cycle progression. The inactivation by roscovitine promotes caspase-mediated apoptosis in leukemic cells.</text>
</comment>
<comment type="subunit">
<text evidence="12 14 15 16 18 20 31 32">Associates primarily with cyclin-H (CCNH) and MAT1 to form the CAK complex. CAK can further associate with the core-TFIIH to form the TFIIH basal transcription factor; this complex is sensitive to UV light. The CAK complex binds to p53/TP53 in response to DNA damage. Interacts with CDK2, SF1/NR5A1, PUF60 and PRKCI.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1245958"/>
<interactant intactId="EBI-448924">
<id>Q01094</id>
<label>E2F1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Perinuclear region</location>
</subcellularLocation>
<text>Colocalizes with PRKCI in the cytoplasm and nucleus. Translocates from the nucleus to cytoplasm and perinuclear region in response to DNA-bound peptides.</text>
</comment>
<comment type="tissue specificity">
<text>Ubiquitous.</text>
</comment>
<comment type="induction">
<text evidence="22">Repressed by DNA-bound peptides.</text>
</comment>
<comment type="PTM">
<text evidence="13 14 30">Phosphorylation of Ser-164 during mitosis inactivates the enzyme. Phosphorylation of Thr-170 is required for activity. Phosphorylated at Ser-164 and Thr-170 by CDK2.</text>
</comment>
<comment type="similarity">
<text evidence="34">Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. CDC2/CDKX subfamily.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/cdk7/"/>
</comment>
<dbReference type="EC" id="2.7.11.22"/>
<dbReference type="EC" id="2.7.11.23"/>
<dbReference type="EMBL" id="X79193">
<property type="protein sequence ID" value="CAA55785.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L20320">
<property type="protein sequence ID" value="AAA36657.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X77743">
<property type="protein sequence ID" value="CAA54793.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X77303">
<property type="protein sequence ID" value="CAA54508.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Y13120">
<property type="protein sequence ID" value="CAA73587.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY130859">
<property type="protein sequence ID" value="AAM77799.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000834">
<property type="protein sequence ID" value="AAH00834.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC005298">
<property type="protein sequence ID" value="AAH05298.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3999.1"/>
<dbReference type="PIR" id="A54820">
<property type="entry name" value="A54820"/>
</dbReference>
<dbReference type="PIR" id="I37215">
<property type="entry name" value="I37215"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001310998.1">
<property type="nucleotide sequence ID" value="NM_001324069.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001310999.1">
<property type="nucleotide sequence ID" value="NM_001324070.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001311000.1">
<property type="nucleotide sequence ID" value="NM_001324071.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001311006.1">
<property type="nucleotide sequence ID" value="NM_001324077.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001790.1">
<property type="nucleotide sequence ID" value="NM_001799.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.184298"/>
<dbReference type="PDB" id="1LG3">
<property type="method" value="Model"/>
<property type="chains" value="A=1-307"/>
</dbReference>
<dbReference type="PDB" id="1PA8">
<property type="method" value="Model"/>
<property type="chains" value="A=181-346"/>
</dbReference>
<dbReference type="PDB" id="1UA2">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.02"/>
<property type="chains" value="A/B/C/D=1-346"/>
</dbReference>
<dbReference type="PDB" id="2HIC">
<property type="method" value="Model"/>
<property type="chains" value="B=13-311"/>
</dbReference>
<dbReference type="PDBsum" id="1LG3"/>
<dbReference type="PDBsum" id="1PA8"/>
<dbReference type="PDBsum" id="1UA2"/>
<dbReference type="PDBsum" id="2HIC"/>
<dbReference type="ProteinModelPortal" id="P50613"/>
<dbReference type="SMR" id="P50613"/>
<dbReference type="BioGrid" id="107457">
<property type="interactions" value="82"/>
</dbReference>
<dbReference type="DIP" id="DIP-5995N"/>
<dbReference type="IntAct" id="P50613">
<property type="interactions" value="23"/>
</dbReference>
<dbReference type="MINT" id="MINT-3018528"/>
<dbReference type="STRING" id="9606.ENSP00000256443"/>
<dbReference type="BindingDB" id="P50613"/>
<dbReference type="ChEMBL" id="CHEMBL3055"/>
<dbReference type="DrugBank" id="DB03496">
<property type="generic name" value="Flavopiridol"/>
</dbReference>
<dbReference type="DrugBank" id="DB02482">
<property type="generic name" value="Phosphonothreonine"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1979"/>
<dbReference type="iPTMnet" id="P50613"/>
<dbReference type="PhosphoSitePlus" id="P50613"/>
<dbReference type="BioMuta" id="CDK7"/>
<dbReference type="DMDM" id="1705722"/>
<dbReference type="EPD" id="P50613"/>
<dbReference type="MaxQB" id="P50613"/>
<dbReference type="PaxDb" id="P50613"/>
<dbReference type="PeptideAtlas" id="P50613"/>
<dbReference type="PRIDE" id="P50613"/>
<dbReference type="DNASU" id="1022"/>
<dbReference type="Ensembl" id="ENST00000256443">
<property type="protein sequence ID" value="ENSP00000256443"/>
<property type="gene ID" value="ENSG00000134058"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000615305">
<property type="protein sequence ID" value="ENSP00000479116"/>
<property type="gene ID" value="ENSG00000277273"/>
</dbReference>
<dbReference type="GeneID" id="1022"/>
<dbReference type="KEGG" id="hsa:1022"/>
<dbReference type="UCSC" id="uc003jvs.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1022"/>
<dbReference type="DisGeNET" id="1022"/>
<dbReference type="GeneCards" id="CDK7"/>
<dbReference type="HGNC" id="HGNC:1778">
<property type="gene designation" value="CDK7"/>
</dbReference>
<dbReference type="HPA" id="CAB004364"/>
<dbReference type="HPA" id="HPA007932"/>
<dbReference type="MIM" id="601955">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P50613"/>
<dbReference type="OpenTargets" id="ENSG00000134058"/>
<dbReference type="PharmGKB" id="PA26314"/>
<dbReference type="eggNOG" id="KOG0659">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XQDH">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00830000128262"/>
<dbReference type="HOGENOM" id="HOG000233024"/>
<dbReference type="HOVERGEN" id="HBG014652"/>
<dbReference type="InParanoid" id="P50613"/>
<dbReference type="KO" id="K02202"/>
<dbReference type="OMA" id="DAEWPHL"/>
<dbReference type="OrthoDB" id="EOG091G0CI9"/>
<dbReference type="PhylomeDB" id="P50613"/>
<dbReference type="TreeFam" id="TF101024"/>
<dbReference type="BRENDA" id="2.7.11.22">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="BRENDA" id="2.7.11.23">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-112382">
<property type="pathway name" value="Formation of RNA Pol II elongation complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-113418">
<property type="pathway name" value="Formation of the Early Elongation Complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167152">
<property type="pathway name" value="Formation of HIV elongation complex in the absence of HIV Tat"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167158">
<property type="pathway name" value="Formation of the HIV-1 Early Elongation Complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167160">
<property type="pathway name" value="RNA Pol II CTD phosphorylation and interaction with CE during HIV infection"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167161">
<property type="pathway name" value="HIV Transcription Initiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167162">
<property type="pathway name" value="RNA Polymerase II HIV Promoter Escape"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167172">
<property type="pathway name" value="Transcription of the HIV genome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167200">
<property type="pathway name" value="Formation of HIV-1 elongation complex containing HIV-1 Tat"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167246">
<property type="pathway name" value="Tat-mediated elongation of the HIV-1 transcript"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-427413">
<property type="pathway name" value="NoRC negatively regulates rRNA expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5696395">
<property type="pathway name" value="Formation of Incision Complex in GG-NER"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-674695">
<property type="pathway name" value="RNA Polymerase II Pre-transcription Events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6781823">
<property type="pathway name" value="Formation of TC-NER Pre-Incision Complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6781827">
<property type="pathway name" value="Transcription-Coupled Nucleotide Excision Repair (TC-NER)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6782135">
<property type="pathway name" value="Dual incision in TC-NER"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6782210">
<property type="pathway name" value="Gap-filling DNA repair synthesis and ligation in TC-NER"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6796648">
<property type="pathway name" value="TP53 Regulates Transcription of DNA Repair Genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6807505">
<property type="pathway name" value="RNA polymerase II transcribes snRNA genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69202">
<property type="pathway name" value="Cyclin E associated events during G1/S transition"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69231">
<property type="pathway name" value="Cyclin D associated events in G1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69273">
<property type="pathway name" value="Cyclin A/B1 associated events during G2/M transition"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69656">
<property type="pathway name" value="Cyclin A:Cdk2-associated events at S phase entry"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-72086">
<property type="pathway name" value="mRNA Capping"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-73762">
<property type="pathway name" value="RNA Polymerase I Transcription Initiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-73772">
<property type="pathway name" value="RNA Polymerase I Promoter Escape"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-73776">
<property type="pathway name" value="RNA Polymerase II Promoter Escape"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-73777">
<property type="pathway name" value="RNA Polymerase I Chain Elongation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-73779">
<property type="pathway name" value="RNA Polymerase II Transcription Pre-Initiation And Promoter Opening"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-73863">
<property type="pathway name" value="RNA Polymerase I Transcription Termination"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-75953">
<property type="pathway name" value="RNA Polymerase II Transcription Initiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-75955">
<property type="pathway name" value="RNA Polymerase II Transcription Elongation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-76042">
<property type="pathway name" value="RNA Polymerase II Transcription Initiation And Promoter Clearance"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-77075">
<property type="pathway name" value="RNA Pol II CTD phosphorylation and interaction with CE"/>
</dbReference>
<dbReference type="SignaLink" id="P50613"/>
<dbReference type="SIGNOR" id="P50613"/>
<dbReference type="EvolutionaryTrace" id="P50613"/>
<dbReference type="GeneWiki" id="Cyclin-dependent_kinase_7"/>
<dbReference type="GenomeRNAi" id="1022"/>
<dbReference type="PRO" id="PR:P50613"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000134058"/>
<dbReference type="CleanEx" id="HS_CDK7"/>
<dbReference type="ExpressionAtlas" id="P50613">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P50613">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0019907">
<property type="term" value="C:cyclin-dependent protein kinase activating kinase holoenzyme complex"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005675">
<property type="term" value="C:holo TFIIH complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0070985">
<property type="term" value="C:TFIIK complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0050681">
<property type="term" value="F:androgen receptor binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004693">
<property type="term" value="F:cyclin-dependent protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008094">
<property type="term" value="F:DNA-dependent ATPase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016301">
<property type="term" value="F:kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008353">
<property type="term" value="F:RNA polymerase II carboxy-terminal domain kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006370">
<property type="term" value="P:7-methylguanosine mRNA capping"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030521">
<property type="term" value="P:androgen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007050">
<property type="term" value="P:cell cycle arrest"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051301">
<property type="term" value="P:cell division"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0000082">
<property type="term" value="P:G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000086">
<property type="term" value="P:G2/M transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006294">
<property type="term" value="P:nucleotide-excision repair, preincision complex assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050821">
<property type="term" value="P:protein stabilization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0000079">
<property type="term" value="P:regulation of cyclin-dependent protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042795">
<property type="term" value="P:snRNA transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006363">
<property type="term" value="P:termination of RNA polymerase I transcription"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006362">
<property type="term" value="P:transcription elongation from RNA polymerase I promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006368">
<property type="term" value="P:transcription elongation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006366">
<property type="term" value="P:transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006361">
<property type="term" value="P:transcription initiation from RNA polymerase I promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006367">
<property type="term" value="P:transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006283">
<property type="term" value="P:transcription-coupled nucleotide-excision repair"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0132">Cell division</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="initiator methionine" description="Removed" evidence="7">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Cyclin-dependent kinase 7" id="PRO_0000085791">
<location>
<begin position="2"/>
<end position="346"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="9">
<location>
<begin position="12"/>
<end position="295"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="9 14">
<location>
<begin position="18"/>
<end position="26"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="9 10 14">
<location>
<position position="137"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="9 14">
<location>
<position position="41"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="7">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="7"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK1 and CDK2" evidence="2 3 8 13 30">
<location>
<position position="164"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK2" evidence="2 4 5 6 8 13 14 30">
<location>
<position position="170"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 5">
<location>
<position position="321"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_023118" evidence="33">
<original>G</original>
<variation>A</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34584424." id="VAR_023119" evidence="17 33">
<original>T</original>
<variation>M</variation>
<location>
<position position="285"/>
</location>
</feature>
<feature type="mutagenesis site" description="Total loss of activity.">
<original>K</original>
<variation>A</variation>
<location>
<position position="41"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhanced capacity to bind ATP analogs." evidence="16">
<original>F</original>
<variation>G</variation>
<location>
<position position="91"/>
</location>
</feature>
<feature type="mutagenesis site" description="No mitotic repression of transcriptional activity of the reconstituted TFIIH complex." evidence="30">
<original>S</original>
<variation>A</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="mutagenesis site" description="Total loss of activity. Total loss of transcriptional activity of the reconstituted TFIIH complex." evidence="28 30">
<original>T</original>
<variation>A</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AAH05298." ref="7" evidence="34">
<original>Q</original>
<variation>R</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; CAA73587." ref="5" evidence="34">
<original>F</original>
<variation>C</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; CAA73587." ref="5" evidence="34">
<original>S</original>
<variation>A</variation>
<location>
<position position="321"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="14"/>
<end position="21"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="24"/>
<end position="30"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="36"/>
<end position="42"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="58"/>
<end position="68"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="77"/>
<end position="81"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="88"/>
<end position="92"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="95"/>
<end position="97"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="98"/>
<end position="102"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="113"/>
<end position="130"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="140"/>
<end position="142"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="143"/>
<end position="145"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="151"/>
<end position="153"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="157"/>
<end position="159"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="161"/>
<end position="163"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="181"/>
<end position="184"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="192"/>
<end position="208"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="218"/>
<end position="229"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="234"/>
<end position="236"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="237"/>
<end position="239"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="257"/>
<end position="260"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="266"/>
<end position="276"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="280"/>
<end position="282"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="286"/>
<end position="290"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="293"/>
<end position="295"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="297"/>
<end position="299"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="304"/>
<end position="307"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1UA2"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10024882"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10882074"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11113184"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15530371"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15695176"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16327805"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17373709"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17386261"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17901130"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19015234"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19071173"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19136461"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19450536"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19667075"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19911397"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20360007"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8069918"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9372954"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9832506"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9840937"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9852112"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source ref="6"/>
</evidence>
<evidence key="34" type="ECO:0000305"/>
<sequence length="346" mass="39038" checksum="0A94BFA7DD416CEB" modified="1996-10-01" version="1">
MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL
REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM
TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRA
PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM
CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG
PTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPKKLIF
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>